Arlyn Arcalas
Exelixis (United States)(US)
Publications by Year
Research Areas
DNA Repair Mechanisms, Protein Kinase Regulation and GTPase Signaling, Microtubule and mitosis dynamics, Glycosylation and Glycoproteins Research, Heat shock proteins research
Most-Cited Works
- → Discovery of XL413, a potent and selective CDC7 inhibitor(2012)90 cited
- → Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90(2012)77 cited
- → Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)(2013)65 cited
- → The design, synthesis, and biological evaluation of PIM kinase inhibitors(2012)37 cited
- → SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors(2012)34 cited
- → Discovery and Characterization of an Inhibitor of Glucosylceramide Synthase(2012)20 cited
- → Erratum to “Discovery of XL413, a potent and selective CDC7 inhibitor” [Bioorg. Med. Chem. Lett. 22 (2012) 3727–3731](2012)6 cited